Dr. Mohamad Walid Ballourah

قسم أورام الدم وأورام الأطفال
مركز الأورام

المنصب الحالي
Consultant, Pediatric Hematology – Oncology
تفاصيل عامة
الجنس:
الذكر
اللغات المنطوقة:
Arabic & English

شهادات التعليم والبورد
1.       Doctor of Medicine Diploma – Damascus School of Medicine, Syria
2.       General Pediatric Residency – American University of Beirut Medical Center, Lebanon
3.       Fellowship – Pediatric Hem/Onc. American University of Beirut Medical Center, Lebanon
4.       Fellowship – Pediatric Hem/Onc. Children’s Cancer Center of Lebanon, Affiliated to St. Jude Children’s Research Hospital, Memphis, TN. USA
5.       Fellowship – Pediatric Hem/Onc. The Hospital for Sick Children- Toronto-Canada
6.       Fellowship Pediatric BMT - The Hospital for Sick Children- Toronto-Canada
7.       Certified in Patient Safety and Quality Improvement. University of Toronto – Toronto- Canada
الخبرة أو التخصص
Pediatric Hematology – Oncology

الأبحاث والمطبوعات
1.       Survival Benefit for Pediatric Patients With Recurrent Ependymoma Treated with Reirradiation. International Journal of Radiation Oncology. 2012. Jan 13
2.       Venous sinus thrombosis leading to stroke in a patient with sickle cell disease on hydroxyurea and high hemoglobin levels: Treatment with thrombolysis. American Journal of Hematology, Aug 1-2008.
3.       Clinical characteristics and outcome of childhood de novo acute myeloid leukemia in Saudi Arabia: A multicenter SAPHOS leukemia group study. Leukemia Research. 49 –(2016 ) 62-72
4.       Pediatric Non-Hodgkin Lymphoma: A Retrospective 7-Year Experience in Children & Adolescents with Non-Hodgkin Lymphoma Treated at King Fahad Medical City (KFMC). Journal of Cancer Therapy, 2015, 6, 299-314
5.       Neuroblastoma in Saudi Children: A Single Center Experience (2006-2014) Journal of Cancer Therapy, 2015, 6, 896-905
6.       Survival benefit with re-irradiation for Recurrent Intracranial Ependymoma in Children. The Hospital for Sick Children, Toronto, ON, Canada. Oral presentation at the 14th International Symposium on Pediatric Neuro-Oncology – ISPNO, June 20 – 23, 2010, Vienna, Austria
7.       Dural Venous Sinus Thrombosis Causing Stroke in a Patient with Sickle Cell Disease on Hydroxyurea. Poster in The 35th Anniversary Convention of the National Sickle Cell Disease Program and the Sickle Cell Disease Association America, Inc. Septemper17-22, 2007; Washington, D.C.
8.       Childhood Cancer is a Curable Disease: Article in English and in Arabic, Newsletter of the Syrian Childhood Cancer Support Association (BASMA).Version 2, P (4-5). July-2007. URL:http://www.basma-syria.org/index.php?option=com_content&task=view&id=34&Itemid=33&lang=en

​